Sorrento Therapeutics Inc. buy melinda
Start price
12.12.17
/
50%
€2.21
Target price
15.12.17
€2.62
Performance (%)
18.37%
End price
15.12.17
€2.62
Summary
This prediction ended on 15.12.17 with a price of €2.62. The BUY prediction by melinda finished with a performance of 18.37%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Sorrento Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | 0.192% | 3.121% | 16.828% | 19.649% |
iShares Nasdaq 100 | 1.245% | 5.051% | 31.022% | 56.928% |
iShares Nikkei 225® | -0.992% | 1.101% | 9.804% | 6.691% |
iShares S&P 500 | 0.154% | 2.864% | 26.511% | 47.657% |
According to melinda what are the pros and cons of Sorrento Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Sorrento Therapeutics Inc. diskutieren
zu folgen
$$
(Zielkurs erreicht)
Stopped prediction by melinda for Sorrento Therapeutics Inc.
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.05
03.01.23
03.01.23
-
03.01.24
03.01.24
-73.34%
28.03.23
28.03.23
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.97
27.12.21
27.12.21
€6.00
27.12.22
27.12.22
-83.85%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.45
16.02.20
16.02.20
€12.00
04.11.21
04.11.21
138.93%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.53
27.03.19
27.03.19
€7.22
30.10.19
30.10.19
-69.82%
30.10.19
30.10.19
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.70
30.12.17
30.12.17
€3.97
02.01.18
02.01.18
10.98%
02.01.18
02.01.18
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.45
12.12.17
12.12.17
€2.90
15.12.17
15.12.17
18.37%
15.12.17
15.12.17
Could be worthwhile Investment >10% per year